Cerebrovascular incidents differ in patients with permanent and paroxysmal atrial fibrillation

Cerebrovascular Diseases

Volumn 22, Issue 5-6, 2006, Pages 446-449

  Staszewski, Jacek ^a   Staszewska, Marzena ^b   Kotowicz, Jerzy ^a   Brodacki, Bogdan ^a   Tomczykiewicz, Kazimierz ^a   Stepien, Adam ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b Wolski Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; EVALUATION STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; INTRACRANIAL EMBOLISM; INTRACRANIAL THROMBOSIS; ISCHEMIC ATTACK, TRANSIENT; MALE; POLAND; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TACHYCARDIA, PAROXYSMAL;

EID: 33750605163     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095288     Document Type: Article

References (16)

1. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk for stroke: the Framingham Study. Stroke 1991;22:983-988.
2. Lip GY, Hee FL: Paroxysmal atrial fibrillation. QJM 2001;94:665-678.
3. Li-Saw-Hee FL, Blann AD, Gurney D, Lip GY: Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation: effects of cardioversion and return of left atrial function. Eur Heart J 2001;22:1741-1747.
4. Fuster V, Ryden LE, Asinger RW, et al: ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001;104:2118-2150.
5. Markides V, Schilling RJ: Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart 2003;89:939-943.
6. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
7. Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC: Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Neurology 1993;43:32-36.
8. Iqbal MB, Taneja AK, Lip GYH, Flather M: Recent developments in atrial fibrillation. BMJ 2005;330:238-243.
9. Kaarisalo MM, Immonen-Raiha P, Marttila RJ, et al: Atrial fibrillation and stroke: mortality and causes of death after the first acute ischemic stroke. Stroke 1997;28:311-315.
10. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL: Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. J Am Coll Cardiol 2000;35:183-187.
11. Fisher CM: Reducing risks of cerebral embolism. Geriatrics 1979;34:59-61.
12. Hylek EM, Go AS, Chang Y, Jensvold N, Henault LE, Selby JV, Singer DE: Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-1026.
13. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria. Stroke 2001;32:2735-2740.
14. Jung DK, Devuyst G, Maeder P, Bogusslavsky J: Atrial fibrillation with small subcortical infarcts. J Neurol Neurosurg Psychiatry 2001;70:344-349.
15. Appelros P, Nydevik I, Seiger A, Terent A: Predictors of severe stroke: influence of preexisting dementia and cardiac disorders. Stroke 2002;33:2357-2362.
16. Loor HI, Groenier KH, Limburg M, Schuling J, Meyboom-de Jong B: Risks and causes of death in a community-based stroke population: 1 month and 3 years after stroke. Neuroepidemiology 1999;18:75-84.